Skip to content
Delayed ~15 min

OSW ONESPAWORLD HOLDINGS LTD

Consumer Discretionary · Russell 2000

Next earnings: not announced yet

What 8 analyst firms say about ONESPAWORLD HOLDINGS LTD: their latest ratings, price targets and how far the stock is from them. How it works

31.13 USD+0.41 (+1.33%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+6.8%to the avg target 33.25 USD+2.12 USD
Buy 6 · Hold 1 · Sell 0

7 rated views · 8 analyst/firm records · 8 firms

Latest report29 Oct 2026avg report date 13 Sep
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8046
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8069

Recent analyst activity · last 90 days

Our tracked history has 5 reports on OSW from 5 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target.

No firm's latest available rating differs from its previous one.

Latest observed target change: Stifel raised its target from $32.00 (set 30 Jul 2026) to $35.00 on 29 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
JefferiesRandal KonikBuy28 Oct 202640.00 USD
Northcoast ResearchAndrew MayBuy30 Jul 202629.00 USD
StifelSteven WieczynskiBuy29 Oct 202635.00 USD
TD CowenMax RakhlenkoBuy29 Oct 2026Conflicting reports · excluded
TruistGregory MillerBuy30 Jul 202629.00 USD
Weiss RatingsUnnamed analyst—29 Oct 2026—
William BlairSharon ZackfiaBuy20 Oct 2026—
Data feed RESEARCHResearch TeamHold16 Mar 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 05:52 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.